PCN61 Healthcare Costs Comparison of Nivolumab Versus Placebo As Adjuvant Treatment of Patients with Melanoma: A Propensity Score Matched Analysis

Abstract

Authors

S. Pandey A. Sharma M.K. Siddiqui A. Amadi

Full Text Cite This Article
Back to Volume 23, Supplemental S2
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×